Fatal connective tissue disease with antinuclear antibodies following PUVA therapy
- PMID: 6203306
Fatal connective tissue disease with antinuclear antibodies following PUVA therapy
Abstract
Antinuclear antibodies with a nucleolar staining pattern appeared in a psoriasis patient during PUVA therapy. No antinuclear antibodies were found after the termination of PUVA but they reappeared one year later together with symptoms consistent with a connective tissue disease. The course was fatal and the clinical and the laboratory investigations suggested a scleroderma-like syndrome.
Similar articles
-
Antinuclear antibodies appearing during PUVA therapy.Acta Derm Venereol. 1985;65(1):31-6. Acta Derm Venereol. 1985. PMID: 2578703
-
Antinuclear antibodies and PUVA photochemotherapy.Arch Dermatol. 1981 Aug;117(8):474-7. Arch Dermatol. 1981. PMID: 6973321
-
Antinuclear antibodies during Puva therapy.Acta Derm Venereol. 1979;59(1):73-5. Acta Derm Venereol. 1979. PMID: 84474
-
Antinuclear antibodies in dermatology.Semin Cutan Med Surg. 2001 Mar;20(1):2-13. doi: 10.1053/sder.2001.23089. Semin Cutan Med Surg. 2001. PMID: 11308133 Review.
-
Connective tissue alterations in skin exposed to natural and therapeutic UV-radiation.Photodermatol. 1985 Feb;2(1):15-26. Photodermatol. 1985. PMID: 3885186 Review.
Cited by
-
PUVA treatment of human cultured fibroblasts from psoriatic skin enhances the binding of antibodies to SSA(Ro).Arch Dermatol Res. 1987;279(3):206-8. doi: 10.1007/BF00413260. Arch Dermatol Res. 1987. PMID: 3592749 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical